SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 188 filers reported holding SORRENTO THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.74 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $14 | -58.8% | 38,853 | 0.0% | 0.00% | -50.0% |
| Q4 2022 | $34 | -99.9% | 38,853 | 0.0% | 0.01% | -50.0% |
| Q3 2022 | $61,000 | -21.8% | 38,853 | 0.0% | 0.01% | -14.3% |
| Q2 2022 | $78,000 | -14.3% | 38,853 | 0.0% | 0.01% | 0.0% |
| Q1 2022 | $91,000 | -49.7% | 38,853 | 0.0% | 0.01% | -46.2% |
| Q4 2021 | $181,000 | -38.9% | 38,853 | 0.0% | 0.03% | -43.5% |
| Q3 2021 | $296,000 | -21.3% | 38,853 | 0.0% | 0.05% | -20.7% |
| Q2 2021 | $376,000 | +17.1% | 38,853 | 0.0% | 0.06% | +11.5% |
| Q1 2021 | $321,000 | +21.1% | 38,853 | 0.0% | 0.05% | +8.3% |
| Q4 2020 | $265,000 | -38.8% | 38,853 | 0.0% | 0.05% | -51.5% |
| Q3 2020 | $433,000 | +77.5% | 38,853 | 0.0% | 0.10% | +76.8% |
| Q2 2020 | $244,000 | +243.7% | 38,853 | 0.0% | 0.06% | +180.0% |
| Q1 2020 | $71,000 | -25.3% | 38,853 | +37.9% | 0.02% | +5.3% |
| Q4 2019 | $95,000 | – | 28,170 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 2,799,790 | $11,059,000 | 3.50% |
| Intellectus Partners, LLC | 1,095,840 | $4,329,000 | 2.20% |
| Cormorant Asset Management, LP | 1,690,800 | $6,679,000 | 0.97% |
| Avoro Capital Advisors LLC | 1,192,130 | $4,709,000 | 0.60% |
| Vident Investment Advisory, LLC | 170,534 | $674,000 | 0.07% |
| GAGNON SECURITIES LLC | 11,116 | $44,000 | 0.02% |
| MATRIX ASSET ADVISORS INC/NY | 22,000 | $87,000 | 0.02% |
| R&F Capital Advisors LP | 12,878 | $51,000 | 0.01% |
| COMMONWEALTH OF PENNSYLVANIA PUBLIC SCHOOL EMPLS RETRMT SYS | 96,154 | $380,000 | 0.01% |
| Virtu KCG Holdings LLC | 27,425 | $108,000 | 0.00% |